MIRA INFORM REPORT

 

 

Report Date :

27.09.2007

 

IDENTIFICATION DETAILS

 

Name :

MEDIPLANTEX NATIONAL PHARMACEUTICAL JOINT-STOCK COMPANY

 

 

Registered Office :

No. 358 Giai Phong Rd., Trung Liet ward, Thanh Xuan Dist, Hanoi

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2006

 

 

Date of Incorporation :

1971

 

 

Legal Form :

Join Stock Company

 

 

Line of Business :

Trading in pharmaceutical, cosmetic, nutritional foods

Trading in materials for pharmaceutical production

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Cler

 

 


 

SUBJECT IDENTIFICATION & LEGAL FORM

 

English Name
 
MEDIPLANTEX NATIONAL PHARMACEUTICAL JOINT-STOCK COMPANY

Vietnamese name

 

CONG TY CO PHAN DUOC TRUNG UONG MEDIPLANTEX

Trade Name

 

MEDIPLANTEX., JSC

Type of Business

 

Join Stock Company

Founded

 

1971

Established Decision

 

No. 406/QD-TCCB

Issued on

 

April 22nd 1993

Issued by

 

Ministry of Health

Former Business Registration

 

No.108216

Issued on

 

May 22nd 1993

Issued by

 

Hanoi Department of Planning and Investment

Equitization Decision

 

No.4410/QD-BYT

Issued on

 

December 7th, 2004

Issued by

 

Ministry of Health

Current Business Registration

 

No. 0103007436

Issued on

 

April 12th, 2005

Issued by

 

Hanoi Department of Planning and Investment

Current Registered Capital

 

37,991,000,000 VND

Former Registered Capital

 

17,000,000,000 VND

Tax Code

 

0100108430

Total Employees

 

600 persons

Qualification

 

Qualified

 

 

ADDRESS

 

Head Office

Address

 

No. 358 Giai Phong Rd., Trung Liet ward, Thanh Xuan Dist, Hanoi

Country

 

Vietnam

Tel

 

(84-4) 8643368 / 8643367 / 8643363

Fax

 

(84-4) 8641584

Email

 

Meplan@fpt.vn

Website

 

www.mediplantex.com

 

Ho Chi Minh City Branch

Address

 

90A/B57 Ly Thuong Kiet Str, Ward.14, Dist 10, Ho Chi Minh city

Country

 

Vietnam

Tel

 

(84-8) 8649948

Fax

 

(84-8) 8649949

 

Dak Lak City Branch

Address

 

No. 249 Nguyen Du Str., Buon Ma Thuot City, Dak Lak province

Country

 

Vietnam

Tel

 

(84-50) 856015

Fax

 

(84-50) 856015

 

Thai Binh Branch

Address

 

No. 311 Tran Hung Dao Str, De Tham Ward, Thai Binh City

Country

 

Vietnam

Tel

 

(84-36) 845565

Fax

 

(84-36) 845565

 

Vinh Phuc Branch

Address

 

Trung Hau Village, Tien Phong Commune, Me Linh Dist, Vinh Phuc Province

Country

 

Vietnam

Tel

 

(84-211) 878345

Fax

 

(84-211) 878345

Chief of factory

 

Mr.HA XUAN SON

Note: This factory has just inaugurate in July 20th 2007

 

 

DIRECTORS

 

1. NAME

 

Mr. TRAN BINH DUYEN

Position

 

General Director

Date of birth

 

March 02nd 1947

ID No.

 

011800636

Issued on

 

July 23rd 1993

Issued by

 

Police of Hanoi city

Resident

 

No.10, 183 Alley Dang Tien Dong, Trung Liet Ward, Dong Da Dist., Hanoi city

Nationality

 

Vietnamese

Contact phone

 

(84-4) 8643363

 

2. NAME

 

Mrs. DOAN HONG THUY

Position

 

Deputy General Director

Contact Address

 

No. 358 Giai Phong Rd., Trung Liet ward, Thanh Xuan Dist, Hanoi

Nationality

 

Vietnamese

Contact phone

 

(84-4) 8647416

 

 

BUSINESS NATURE AND ACTIVITIES

 

The subject registered in the following lines of business:

-          Trading in pharmaceutical, cosmetic, nutritional foods

-          Trading in materials for pharmaceutical production

-          Import and export service

-          Trading medical equipments

-           

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT: The subject imports from Canada (Tenamid Corp), Denmark, France, India, Korea 

EXPORT: The subject exports to Japan, China, Laos, Cambodia, Russia  

 

 

BANKERS

 

1. BANK FOR FOREIGN TRADE OF VIETNAM (VIETCOMBANK)

Address

 

No. 198 Tran Quang Khai Str., Hanoi City, Vietnam

Tel

 

(84-4) 824 0976

Fax No

 

(84-4) 826 9067

Account No (USD)

 

001.1.37.00.77080

Account No (VND)

 

001.1.00.00.13526

Note: The given address (4749 Ly Thai To, Hanoi) and A/C (362111370068) is not correct.

 

2. INDUSTRIAL AND COMMERCIAL BANK OF VIETNAM – DONG DA BRANCH

Address

 

No. 187 Tay Son Str, Dong Da Dist, Hanoi City, Vietnam

Tel

 

(84-4) 851620

Account No (USD)

 

10202.00000.6931

 

 

SHAREHOLDERS

 
1. Name
 
VIETNAM PHARMACEUTICAL CORPORATION
Address
 
No. 138B Giang Vo Str, Hanoi City, Vietnam
Tel
 
(84-4) 8443153
Fax
 
(84-4) 8443665
Representative person
 
Mr. TRAN BINH DUYEN
Resident
 
No. 10, 183 Alley Dang Tien Dong, Trung Liet Ward, Dong Da Dist., Hanoi city

Share

 

47,600 shares

 

3. Name

 

663 OTHER SHAREHOLDERS

Position

 

Shareholder

Share

 

232,486 shares

 

 

PAYMENT HISTORY AND EXPERIENCES

 

Trade Morality

 

Fairly Good

Liquidity

 

Average

Payments

 

Above Average

Financial Situation

 

Above Average

Development trend

 

Fairly Good

Litigation Data

 

No reported

Bankruptcy

 

No reported

Payment Method

 

TT, L/C

Sale Method

 

Supplying for agents, customers

 

 

FINANCIAL DATA

BALANCE SHEET

Unit: VND Million

Balance sheet date

31/12/06

31/12/05

31/12/04

31/12/03

Number of weeks

52

52

52

52

ASSETS

A. Working assets & short-term Investment

239,952

252,659

211,314

174,907

I. Cash and cash equivalents

9,184

7,749

6,282

3,108

II. Short-term investment

0

0

0

0

 1. Short-term securities investment

0

0

0

0

 2. Other short-term investment

0

0

0

0

 3. Provision for short-term investment

0

0

0

0

III. Receivables

127,614

116,963

94,939

81,029

1. Receivables from customers

109,255

96,908

83,356

73,746

 2. Prepayment for providers

8,981

6,592

9,760

6,931

 3. Value-added tax deducted

973

2,133

1,789

786

 4. Internal receivables

0

10,851

115

0

 5. Other receivables

8,405

479

328

0

 6. Provision for bad receivables

0

0

-409

-434

IV. Inventory

100,081

124,160

108,196

89,260

 1. Purchased goods in transit

0

0

0

0

 2. Raw materials

0

4,347

3,840

5,991

 3. Instrument, tools

0

1,840

1,702

1,671

 4. Cost for production and business in process

0

620

2,290

803

 5. End products

0

0

0

0

 6. Goods

100,081

117,353

100,364

80,795

 7. Goods on consignment

0

0

0

0

 8. Provision for devaluation of stocks

0

0

0

0

V. Other current assets

3,073

789

624

485

 1. Advances

0

519

588

433

 2. Prepaid expenses

50

0

0

52

 3. Pending expenses for transfer

0

0

0

0

 4. Tax and accounts receivable to State budget

0

0

0

0

 5. Other current assets

3,023

270

36

0

VI. Administrative

0

2,998

1,273

1,025

 1. Administrative expenses for previous year

0

2,998

0

0

 2. Administrative expenses for current year

0

0

1,273

1,025

B. Fixed assets & Long term investment

59,430

16,756

11,879

11,998

I.  Fixed assets

57,317

16,756

11,879

11,998

1. Tangible fixed assets

51,712

16,756

11,879

11,998

   + Original cost

68,306

31,686

24,902

22,504

   + Accumulated depreciation value

-16,594

-14,930

-13,023

-10,506

2.  Financial leasing fixed assets

0

0

0

0

   + Original cost

0

0

0

0

   + Accumulated depreciation value

0

0

0

0

3. Intangible fixed assets

5,605

0

0

0

   + Original cost

5,605

0

0

0

   + Accumulated depreciation value

0

0

0

0

II. Long term investment

1,153

0

0

0

1. Long-term securities investment

0

0

0

0

2. Joint-venture capital contribution

1153

0

0

0

3. Other long-term investment

0

0

0

0

4. Provision for long-term investment devaluation

0

0

0

0

III. Capital construction in process

0

0

0

0

IV. Other

960

0

0

0

TOTAL ASSETS

299,382

269,415

223,193

186,905

LIABILITIES

A. Payable loans

242,198

242,999

200,775

168,271

I. Short term payables

233,632

240,826

197,802

163,822

1. Short-term borrowings

149,141

173,529

160,448

130,580

2. Due long-term liabilities

0

0

0

0

3. Payables to supplier

60,698

56,981

33,846

38,646

4. Prepayment of buyer

10,553

8,495

5,976

5,958

5. Taxes and accounts dutiable

1,502

-7,024

-5,358

-11,359

6. Employee payments

0

0

12

10

7. Internal payables

0

0

0

0

8. Other payables

11,738

8,845

2,878

-13

II. Long term loans

8,566

2,173

2,973

4,449

1. Long-term borrowings

8,566

2,173

2,973

4,449

2. Long-term payables

0

0

0

0

III. Other payables

0

0

0

0

1. Payable expenses

0

0

0

0

2. Pending assets

0

0

0

0

3. Receipts long-term collateral and deposit

0

0

0

0

B. Owner’s Equity

57,184

26,416

22,418

18,634

I. Capital and Funds

55,670

22,409

20,287

16,923

1. Working capital

37,683

16,692

16,693

15,886

2. Differences from asset revaluation

0

0

0

0

3. Exchange rate differences

0

0

0

0

4. Development investment funds

310

310

310

0

5. Reserved funds

8,396

0

0

0

6. Retained profit

6,521

2,593

470

1,037

7. Construction capital sources

2,760

2,814

2,814

0

II. Other administrative and fund sources

1,514

4,007

2,131

1,711

1. Provident funds for unemployment

0

0

0

0

2. Reward and welfare funds

288

288

311

125

3. Management funds of higher level

0

0

0

0

4. Functional operation funds

978

3,399

1,820

1,586

Current year

978

3,399

1,366

256

Last year

0

0

454

1,330

5. Fund sources formed by fixed assets

248

320

0

0

TOTAL LIABILITY AND EQUITY

299,382

269,415

223,193

186,905

 

PROFIT & LOSE STATEMENT

 

Description

FY 2006

FY 2005

FY 2004

FY 2003

Total revenue

463,867

474,458

440,736

396,293

Deductions Items

38

33

5,023

3

- Discount

-

0

0

0

- Devaluation

-

0

3

0

- Return of sold goods

-

0

4,996

3

- Turnover tax, Luxury tax & Export tax

-

33

24

0

1. Net revenue

463,829

474,425

435,713

396,290

2. Cost of goods sold

424,793

440,755

404,576

368,485

3. Gross Profit

39,036

33,670

31,137

27,805

4. Sales expenses

13,446

11,135

10,955

11,161

5. Enterprise administrative expenses

9,567

8,923

10,453

9,655

6. Net income from business activities

16,023

13,612

9,729

6,989

Income from financial activities

4,780

2,444

1,089

555

Expenditure from financial activities

14,821

13,901

10,148

9,497

7. Net income from financial operation

-10,041

-11,457

-9,059

-8,942

Irregular income

361

0

3

2,559

Irregular expenditure

1,653

26

15

3

8. Irregular Profit

-1292

-26

-12

2,556

9. Total pre-tax profit

4,690

2,129

658

603

10. Income tax

0

596

184

193

11. After tax profit

4,690

1,533

474

410

 

 

FINANCIAL FACTORS

 

Description

FY 06

FY 05

FY 04

FY 03

Current liquidity ratio

1.03

1.05

1.07

1.07

Quick Liquidity ratio

0.60

0.53

0.52

0.52

Inventory circle

4.24

3.79

4.10

8.26

Average receive period

100.42

89.99

79.53

74.63

Utilizing Asset Performance

1.55

1.76

1.95

2.12

Liability/ Total Asset (%)

80.90

90.20

89.96

90.03

Liability/ Owner's equity (%)

423.54

919.89

895.60

903.03

Income before tax/ Total asset (%) ROA

1.57

0.79

0.29

0.32

Income before tax/ Owner's equity (%) ROE

8.20

8.06

2.94

3.24

Gross Profit / Total revenue (%) GPM

8.42

7.10

7.06

7.02

Income before tax/ Total revenue (%) NPM

1.01

0.45

0.15

0.15

 

 

INTERPRETATION

 

Mediplantex is now a Joint Stock Company. The former type of the subject was a state-owned company, which was established in 1971.

 

The subject has been operated in the fields of plantation, production, and export of various species of material pharmacy from medical plants for many years such as Artemisia annual, Saphora japonica, Peppermint, etc. The subject has business relationship with over 20 foreign partners all over the world. The position in the industry of the subject is good.

 

The subject’s premises are large. The management capability of the subject is average. The subject now focuses on planting medicinal plants, processing and export of material for foreign manufacturers. Besides, the subject is also a large trader in pharmaceutical industry. The subject imports and trades a large amount of products in Northern region of Vietnam. The subject has factory with GMP certificate to manufacture some kind of drugs. On July 20th 2007, the factory No.2 in Vinh Phuc province was inaugurated and put into operation with total investment capital of about 60 billion VND. The market share of the subject is large. Now, the subject exports products to Laos, Myanmar, India, Russia.

 

The turnover of the subject is increasing. Its financial status is normal. The long term loans are still high despite a slightly decrease in 2005 compared with that of 2004. According to the result of audited report, total assets of the subject as of 31/12/2006 was 299,3 billion VND, increased in comparison with the year 2005 of 32,9 billion VND, total revenue was 463,8 billion, gross profit was about 40 billion VND. As for our observation, the business activities of the subject seem to be busier than before. However, like many other state-owned companies, it is not really active and professional in doing business. Its staffs are graded at normal. Nevertheless, the subject will gradually catch up with the changes of globalization with its new form of owner after equitization. Its prospect seems to be bright.

 

In short, the operation and finance are regard good. The business of the subject is stable and development. The subject has capacity to meet the financial commitments. No caution needed for the business transactions.

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions